Clinical Sciences

Scientists and leading transplant surgeons from the University of Edinburgh’s SensiBile project team have partnered with Integrated Graphene to develop a point-of-care biomedical test that will revolutionise the safety of liver transplants.

BioCaptiva has announced an oversubscribed £2.1 million additional seed financing to complete the first in-human trial with the BioCaptis.

US biotech company Neurogene has announced that a new 'product candidate' for the treatment of Rett syndrome has been added to its development pipeline.

Resolution Therapeutics, a biopharmaceutical spinout company developing macrophage cell therapy to treat advanced liver disease, has completed a £10 million financing extension from Syncona and announced a new collaboration with biotech firm panCELLa.

Kynos Therapeutics, a spinout company launched with Edinburgh Innovations' support, has raised £9 million to progress development of therapies at the interface of inflammation, immunity and metabolism.

Edinburgh Innovations clients have scooped two of the four Scottish AccelerateHER Awards 2022 for inspiring female founders.

Boehringer Ingelheim, one of the world’s largest pharmaceutical companies, is supporting University of Edinburgh researchers to develop the commercial potential of their work.

University of Edinburgh researchers are spearheading efforts to combat Non-Alcoholic Fatty Liver Disease (NAFLD)